1.Long-Term Efficacy and Safety of Thermal Balloon Endometrial Ablation for Patients with Menorrhagia
Yanna LI ; Jun ZHANG ; Tao LIU
Chinese Journal of Minimally Invasive Surgery 2005;0(10):-
Objective To evaluate the long-term efficacy and safety of thermal balloon endometrial ablation (TBEA) for patients with menorrhagia. Methods From February 2004 to January 2008,105 women with menorrhagia was admitted to our hospital and treated by TBEA. The clinical data,including menstrual cycle and blood volume,as well as TBEA complications such as abdominal pain,infection,bleeding and conglutination,were followed up for a long period in the patients. Results Among the 105 patients,two were lost for follow-up,and one died of malignant tumor of the urinary system in 56 days after the TBEA,the other 102 (97.1%) patients achieved an follow-up for 3 (102 patients),6 (101 patients),12 (99 patients),24 (66 patients),or 36 months (51 patients) succesively. At each of the time point,the success/amenorrhea rates were 93.1% (95/102)/38.2% (39/102),93.1% (94/101)/33.7% (34/101),91.9% (91/99)/32.3% (32/99),93.9% (62/66)/34.8% (23/66),and 92.2% (47/51)/31.4% (16/51),respectively. No severe perioperative complications such as perforation of the uterus and adjacent organs,massive bleeding or infection due to mechanical or thermal injuries occurred. After the operation,11 (10.5%) patients had uterus contraction-like pain,which was relieved by analgesic drugs within 6 hours;8 (7.9%) patients had adhesion of the tissues around the cervix uteri and/or uterine cavity,4 of them were cured by dilation of the uterus,3 received surgical separation,and 1 underwent resection of the uterus. No significant difference in the effective rate and rate of amenorrhea was found between the 36-and 12-month follow-up results (?2=0.000,P=1.000 and ?2=0.014,P=0.906,respectively),or between 24-and 12-month follow-up results (?2=0.034,P=0.854;?2=0.114,P=0.736). Conclusion TBEA shows good long-term efficacy and safety,as an applicable alternative in the treatment of menorrhagia.
2.The Effects of Hemodialysis and Continuous Veno-venous Hemofiltration on Serum HGF in Patients with Acute Renal Failure
Jun ZHANG ; Lijian TAO ; Jianping NIGN
Journal of Chinese Physician 2001;0(02):-
Objective To indentify the effect of hemodialysis(HD) and continuous veno-venous hemofiltration (CVVH) on serum hepatocyte growth factor (HGF) in the patients with acute renal failure (ARF). Methods Of 28 patients with ARF, 19 received HD and 9 underwent CVVH. HGF concentrations in patients serum and ultrafiltrate were measured by ELISA. Results Compared with the controls, serum HGF concentration increased significantly in ARF patients (P
3.Familial osteopoikilosis in the pelvic region combined with bilateral gluteal muscle contracture: a case report.
Xin-Tao ZHANG ; De-Ming XIAO ; Jun-Jun SHI ; Wen-tao ZHANG
China Journal of Orthopaedics and Traumatology 2013;26(3):246-247
Adolescent
;
Contracture
;
complications
;
Humans
;
Male
;
Osteopoikilosis
;
complications
;
genetics
;
Pelvis
5.Free superficial iliac circumflex artery skin flap: the clinical application and management of donor site defects.
Jun-Tao HAN ; Song-Tao XIE ; Ke TAO ; Wan-Fu ZHANG ; Peng JI ; Da-Hai HU
Chinese Journal of Plastic Surgery 2013;29(3):175-177
OBJECTIVETo investigate the clinical application of free superficial iliac circumflex artery skin flaps, as well as the management of donor site defects.
METHODS17 free superficial iliac circumflex artery skin flaps were applied for the traumatic defects or deformities on face, neck, foot, hand, ankle and lower leg, respectively. The donor site defects were closed directly or covered by paraumbilical island flaps.
RESULTSThe 17 flap size ranged from 5 cm x 3 cm to 19 cm x 14 cm. 16 flaps survived completely except 1 flap with partial necrosis, which was closed by free skin graft. The donor site defects were closed directly in 10 cases, and covered by paraumbilical island flaps in 7 flaps without no flap necrosis. The abdomen had a good appearance.
CONCLUSIONSGood appearance can be achieved with free superficial iliac circumflex artery skin flaps for the defects on face, neck, foot, hand, ankle and lower leg. Paraumbilical island flap can be used for the donor site defects.
Arteries ; Foot ; Free Tissue Flaps ; blood supply ; transplantation ; Humans ; Reconstructive Surgical Procedures ; Skin ; Skin Transplantation ; Transplant Donor Site ; surgery ; Wounds and Injuries ; surgery
6.Effect of maternal obesity on children's mental status
Lulu ZHANG ; Yexuan TAO ; Jun ZHANG ; Lisu HUANG
Chinese Journal of Applied Clinical Pediatrics 2016;31(7):551-553
In recent years,obesity is becoming one of the focus problems of social public concern.Maternal obesity may pose a threat on maternal health,for examble the increase of obstetrical complications,it may also affect the short-term and long-term health of the offspring.Maternal obesity may affect children's mental disorder,no review to date has discussed it systematically in China.Now,the health hazards of maternal obesity for the offspring including childhood autism spectrum disorder,attention deficit hyperactivity disorder,neural tube defects,neurobehavioral development disorders and so forth were reviewed,and to provide a reasonable guidance of obesity management.
7.Cardiovascular diseases comorbid with mental disturbances in inpatients of cardiology department
Min ZHANG ; Na LI ; Jun YANG ; Tao GUO
The Journal of Practical Medicine 2016;32(4):653-655,656
Objective Cardiovascular diseases comorbid with mental disturbances are described as psycho-cardiology diseases, which have been paid attention increasingly. The aim of this study is to summarize and analyze the findings about the study of psycho-cardiology over a year , and to obtain the baseline data of psycho-ca rdiology diseases in inpatients of cardiology department. Methods Subjects in this study were inpatients of cardiology department in the First Affiliated Hospital of Kunming Medical University in the past 21 months. The demographic and clinical data of the inpatients were collected. Anxiety and depression were evaluated by the Hospital Anxiety and Depression Scale. The prevalence of anxiety and depression in patients with various cardiovascular diseases were calculated respectively. To detect the potential risk factors of anxiety or depression, two logistic regression models were established. Results The prevalence of anxiety, depression, anxiety and/or depression, and anxiety comorbid with depression was 38.6%, 12.4%, 51.0%, and 7.9%,respectively. The prevalence of depression in patients with chronic heart failure was 24.6%, which was higher than the general level and that of patients with other cardiovascular diseases. The prevalence of anxiety in patients with acute myocardial infarction, arrhythmia, and hypertension ranged from 39.6% to 41.7%. The long course of diseases, multiple diseases, and the history of cardiac interventional operation were the common risk factors for anxiety and depression. Conclusion Anxiety and depression are common in patients with cardiovascular diseases. Cardiologists should take mental disturbances seriously, and pay more attention to the patients with above risk factors.
8.Content Change of CollagenⅠ, Ⅲ in Liver and Spleen of Patients with Advanced Schistosomiasis Japonica
Jialin CHEN ; Jun TAO ; Weimin CAI ; Yanping ZHANG
Chinese Journal of Parasitology and Parasitic Diseases 1997;0(06):-
Objective To study the change of the content of collagen typeⅠand collagen type Ⅲ (C-Ⅰ, C-Ⅲ) in liver and spleen of patients with advanced schistosomiasis japonica. Methods Sirius red staining was used to examine pathologically the liver and spleen biopsy materials from 55 patients at the advanced stage of schistosomiasis and 5 healthy persons as control. The stained slides were observed under polarizing microscope and results were interpreted by computer imaging analysis system. (Results) The content of C-Ⅰand C-Ⅲ in liver tissue and hepatic sinusoids increased significantly in the patients than that of the control (P
9.Mononuclear cells count can reliably predict hematopoietic reconstitution following allogeneic peripheral blood stem cell transplantation
Liang WANG ; Kanger ZHU ; Tao ZHANG ; Jie CHEN ; Jun ZHONG
Chinese Journal of Practical Internal Medicine 2001;0(03):-
0.05).There was a positive correlation between the tempo of the engraftment and the progressive increase of the doses of MNC in the range of (3~5.99)?108/kg,but which was not found in the range of 6?108/kg.Conclusion These results indicate that MNC taken as an index for the measurement of the hematopoietic stem cell/progenitor content can reliably predict hematopoietic reconstitution after both HLA-matched and-mismatched sibling donor peripheral blood stem cell transplantation,with the rate and tempo of engraftment comparable with that in CD34+ cell group,and however,the target dose was reached with one apheresis in all 83 donors in MNC group(100%),as compared with 14 donors in CD34+ cell group(37.84%),suggesting that MNC may replace CD34+ cell as an independent index for the assessment of the stem cell/progenitor content in clinical practice.
10.Bioavailability of Silymarin-loaded Nanoparticles
Ziran ZHANG ; Mancang CHEN ; Jun HE ; Jiansheng TAO
Chinese Traditional Patent Medicine 1992;0(03):-
AIM:To study the oral bioavailability of Silymarin-loaded Nanoparticles(SM-NP). METHODS: Beagle dogs were employed as experiment animals,Yiganling Tablet and Silymarin Extraction were used as the reference preparations.Three constituents were isolated on Ultimate~(TM) AQ-C_(18) column with mobile phase methanol:water(50∶50) at 0.8 mL/min flow rate using gradient elution and ESI ionic source and negative ion detection.Silybin plasma concentration in rat was determined by LC-M. RESULTS: The pharmacokinetics of the tested preparation and Yiganling Tablet met with one-compartment model.The relative bioavailability of three components of SMNP were higher than that of Yiganling Tablet. CONCLUSION: The results indicate that SM-NP has better bioavailability than the reference preparation,which confirms that nanoparticles is a good carrier for improving oral bioavailability of poorly-soluble drugs.